Home
English
English
简体中文
Sign In
Help Desk
Journals
Advanced Search
BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Featured Articles
Journals
Submit a Manuscript
Articles Published Processes
Keyword:
Inflammatory bowel disease
1
Telemedicine in inflammatory bowel diseases: A new brick in the medicine of the future?
9/20/2023 7:36:10 AM |
Browse: 18 |
Download: 0
2
Diabetes exacerbates inflammatory bowel disease in mice with diet-induced obesity
9/1/2023 8:11:23 AM |
Browse: 48 |
Download: 130
3
Pregnancy and medications for inflammatory bowel disease: An updated narrative review
3/7/2023 8:12:13 AM |
Browse: 102 |
Download: 312
4
Are we ready for telemonitoring inflammatory bowel disease? A review of advances, enablers, and barriers
2/21/2023 6:19:16 AM |
Browse: 101 |
Download: 266
5
Major depressive disorders in patients with inflammatory bowel disease and rheumatoid arthritis
2/6/2023 6:38:44 AM |
Browse: 103 |
Download: 406
6
Artificial intelligence and inflammatory bowel disease: Where are we going?
1/12/2023 10:19:09 AM |
Browse: 120 |
Download: 386
7
Modern drug discovery for inflammatory bowel disease: The role of computational methods
1/6/2023 2:52:58 AM |
Browse: 119 |
Download: 410
8
Intestinal microecology-based treatment for inflammatory bowel disease: Progress and prospects
1/5/2023 3:12:10 AM |
Browse: 105 |
Download: 402
9
Unveiling the biological role of sphingosine-1-phosphate receptor modulators in inflammatory bowel diseases
1/4/2023 5:53:02 AM |
Browse: 117 |
Download: 251
10
Role of the combination of biologics and/or small molecules in the treatment of patients with inflammatory bowel disease
12/19/2022 10:48:04 AM |
Browse: 137 |
Download: 307
11
Do inflammatory bowel disease patient preferences from treatment outcomes differ by ethnicity and gender? A cross-sectional observational study
12/14/2022 7:20:14 AM |
Browse: 103 |
Download: 530
12
Predictors of bowel damage in the long-term progression of Crohn’s disease
11/23/2022 9:44:44 AM |
Browse: 124 |
Download: 532
13
Quality of care in patients with inflammatory bowel disease from a public health center in Brazil.
11/23/2022 9:44:44 AM |
Browse: 122 |
Download: 713
14
Pathogenesis of adherent invasive Escherichia coli and its role in inflammatory bowel disease
11/8/2022 7:44:25 AM |
Browse: 140 |
Download: 514
15
New insights into the interplay between intestinal flora and bile acids in inflammatory bowel disease
10/21/2022 2:24:58 AM |
Browse: 144 |
Download: 393
16
Gastrointestinal histoplasmosis complicating pediatric Crohn disease: A case report and review of literature
10/12/2022 7:58:25 AM |
Browse: 187 |
Download: 541
17
Electrical neuromodulation therapy for inflammatory bowel disease
9/22/2022 1:26:05 AM |
Browse: 157 |
Download: 506
18
Myocarditis as an extraintestinal manifestation of ulcerative colitis: A case report and review of the literature
9/16/2022 11:52:44 AM |
Browse: 148 |
Download: 566
19
Urotensin II level is elevated in inflammatory bowel disease patients
9/15/2022 1:37:25 PM |
Browse: 171 |
Download: 474
20
Diet and nutrition against inflammatory bowel disease: Trick or treat(ment)?
9/14/2022 8:34:39 AM |
Browse: 212 |
Download: 527
21
Efficacy of cytapheresis in patients with ulcerative colitis showing insufficient or lost response to biologic therapy
9/7/2022 8:29:04 AM |
Browse: 287 |
Download: 531
22
Prevalence and factors associated with vitamin C deficiency in inflammatory bowel disease
8/31/2022 11:27:52 AM |
Browse: 206 |
Download: 610
23
Effectiveness, safety, and drug sustainability of biologics in elderly patients with inflammatory bowel disease: A retrospective study
8/31/2022 11:27:52 AM |
Browse: 204 |
Download: 666
24
Colon mucus in colorectal neoplasia and beyond
8/26/2022 7:50:06 AM |
Browse: 217 |
Download: 541
25
Probiotic treatment of Inflammatory Bowel Disease: Its extent and intensity
8/22/2022 12:18:01 PM |
Browse: 251 |
Download: 514
26
Type 2 autoimmune pancreatitis associated with severe ulcerative colitis: Three case reports
8/16/2022 1:35:32 AM |
Browse: 177 |
Download: 460
27
Influence of SCENIC recommendations on terminology used for histopathologic diagnosis of inflammatory bowel disease-associated dysplasia
8/10/2022 1:14:37 PM |
Browse: 215 |
Download: 550
28
Trends in medication use and treatment patterns in Chinese patients with inflammatory bowel disease
8/10/2022 8:23:14 AM |
Browse: 192 |
Download: 719
29
Serological profiling of Crohn’s disease and ulcerative colitis patients reveals anti-microbial antibody signatures
8/10/2022 8:23:14 AM |
Browse: 193 |
Download: 804
30
Gut microbiota, inflammatory bowel disease and colorectal cancer
8/10/2022 8:23:14 AM |
Browse: 195 |
Download: 600
31
High-fat diet aggravates colitis via mesenteric adipose tissue derived exosome metastasis-associated lung adenocarcinoma transcript 1
8/3/2022 7:54:39 AM |
Browse: 201 |
Download: 631
32
Comment on “Disease exacerbation is common in inflammatory bowel disease patients treated with immune checkpoint inhibitors for malignancy”
8/1/2022 9:20:54 AM |
Browse: 212 |
Download: 531
33
Network pharmacology and molecular docking reveal zedoary turmeric-trisomes in Inflammatory bowel disease with intestinal fibrosis
7/22/2022 7:03:58 AM |
Browse: 155 |
Download: 639
34
Update on gut microbiota in gastrointestinal diseases
7/22/2022 7:03:58 AM |
Browse: 184 |
Download: 452
35
Apheresis: A cell-based therapeutic tool for the inflammatory bowel disease
7/11/2022 8:36:00 AM |
Browse: 223 |
Download: 553
36
Prevalence, phenotype and medication for the pediatric inflammatory bowel disease population of a state in Southeastern Brazil
7/6/2022 1:21:32 PM |
Browse: 248 |
Download: 743
37
Characteristics of inflammatory bowel diseases in patients with concurrent immune-mediated inflammatory diseases
7/4/2022 12:30:52 PM |
Browse: 219 |
Download: 610
38
Patient-derived organoids for therapy personalization in inflammatory bowel diseases
6/24/2022 1:12:05 PM |
Browse: 269 |
Download: 597
39
Higher infliximab and adalimumab trough levels are associated with fistula healing in patients with fistulising perianal Crohn’s disease
6/16/2022 1:07:50 PM |
Browse: 247 |
Download: 681
40
Fecal microbiota transplantation in the metabolic diseases: Current status and perspectives
6/16/2022 1:07:50 PM |
Browse: 222 |
Download: 513
41
Updates in therapeutic drug monitoring in inflammatory bowel disease
6/2/2022 12:11:47 PM |
Browse: 300 |
Download: 735
42
CD8-positive indolent T-Cell lymphoproliferative disorder of the gastrointestinal tract: A case report and review of literature
5/24/2022 2:32:33 PM |
Browse: 160 |
Download: 497
43
Increasing thirty-day readmissions of Crohn’s disease and ulcerative colitis in the United States: A national dilemma
5/18/2022 11:24:37 AM |
Browse: 277 |
Download: 682
44
Emerging role of biosimilars in the clinical care of inflammatory bowel disease patients
5/13/2022 8:46:12 AM |
Browse: 216 |
Download: 621
45
Epidemiological characteristics of Asian children with inflammatory bowel disease at diagnosis: Insights from an Asian-Pacific multi-centre registry network
4/29/2022 6:42:52 AM |
Browse: 267 |
Download: 855
46
Learning models for colorectal cancer signature reconstruction and classification in patients with chronic inflammatory bowel disease
4/28/2022 1:59:56 PM |
Browse: 251 |
Download: 782
47
Therapeutic drug monitoring in inflammatory bowel disease treatments
4/15/2022 8:25:28 AM |
Browse: 231 |
Download: 517
48
Effect of enhanced recovery after surgery on inflammatory bowel disease surgery: A meta-analysis
4/8/2022 12:06:55 PM |
Browse: 223 |
Download: 501
49
Therapeutic drug monitoring in inflammatory bowel disease: At the right time in the right place
3/30/2022 3:20:26 PM |
Browse: 235 |
Download: 370
50
Jianpi Qingchang Bushen decoction improves inflammatory response and metabolic bone disorder in inflammatory bowel disease-induced bone loss
3/30/2022 3:20:26 PM |
Browse: 297 |
Download: 1009
Page 1 of 14 ( 659 items )
<<
1
2
3
4
5
6
7
8
9
...
14
>>
Write to the Help Desk
© 2004-2023 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345